Fundology

SBIX holdings

As of , SBIX (Invesco NASDAQ Biotech UCITS ETF, ISIN IE00BQ70R696) has 239 holdings on our record. The fund reports 244 positions in all. Weights are shares of the whole fund.

SBIX: price, returns and charges

Holdings
239
244 reported in all
Ten largest
48.2%
of the whole fund
Effective number of holdings
29
As concentrated as this many equal-sized holdings (how it is worked out)
Largest holding
9.0%
Gilead Sciences

Map of the largest holdings

The 10 largest holdings of SBIX, together 48.2% of the fund. Each tile’s area is its share of the whole fund; the colour is its sector. Signed-in members can read every holding in the Holdings tab.

Gilead Sciences (GILD): 9.03% of the fund · Not classifiedGilead Sciences9.0%Amgen (AMGN): 8.55% of the fund · Not classifiedAmgen8.6%Vertex Pharmaceuticals (VRTX): 7.84% of the fund · Not classifiedVertex Pharmaceuticals7.8%Regeneron Pharmaceuticals (REGN): 6.19% of the fund · Not classifiedRegeneron Pharmaceuticals6.2%Moderna (MRNA): 5.95% of the fund · Not classifiedModerna6.0%Revolution Medicines (RVMD): 2.43% of the fund · Not classifiedRevolution Me…2.4%Biogen (BIIB): 2.38% of the fund · Not classifiedBiogen2.4%Illumina (ILMN): 2.04% of the fund · Not classifiedILMN2.0%Royalty Pharma · Class A (RPRX): 1.97% of the fund · Not classifiedRPRX2.0%Roivant Sciences (ROIV): 1.86% of the fund · Not classifiedROIV1.9%
  • Other and not classified 48.2%

Weights of the whole fund, as of 12/11/2026. The same holdings as a list

As of

More:SBIX: key facts, returns and chargesCompare what it holds with another fundHoldings overlapHow overlap is measured

Holdings and weights are as published on 12/11/2026 and change as the fund trades. This is information, not advice.